The following products will be transferred from Smithkline Beecham Pharmaceuticals to Goldshield Pharmaceuticals Ltd from April 17: Dyazide (hydrochlorothiazide 25mg, triamterene 50mg) tablets 75mg, pack size 30; Dyspamet (cimetidine) suspension 200mg/5ml, pack size 600ml; Parnate (tranylcypromine sulphate) tablets 10mg, pack size 28.